Weighing the cost of technology advances in medical devices
A New York Times op-ed entitled “In Cancer Care, Cost Matters,” described what may be one of the earliest accounts where doctors at Sloan-Kettering decided not to use a new cancer drug because of its extra cost when they were already using equally-effective drugs for their cancer treatments. The article piqued my interest. These days for any doctor who uses expensive technologies, it is easy to see where this evaluation …









![Cancer care's financial toxicity [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-1-190x100.jpg)



![New data reveals the massive pay gap for women ER doctors [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-4-190x100.jpg)
